This uncontrolled systemic inflammation strongly links COVID-19 with a specific polygenic autoinflammatory disease, such as AOSD, and, in fact, many drugs commonly used for the treatment of AOSD have been also approved for COVID-19 disease, such as the IL-1 inhibitor Anakinra (4–6). The gene discussed is IL1B; the disease is adult-onset Still disease.